Naratriptan盐酸盐是5-HT1受体激动剂,可作用于偏头疼。
Naratriptan is a triptan agent that is used for the treatment of migraine headaches.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Demet Akin, et al. Agonist-directed trafficking explaining the difference between response pattern of naratriptan and sumatriptan in rabbit common carotid artery. Br J Pharmacol. 2002 May; 136(2): 171–176. doi: 10.1038/sj.bjp.0704710
[2] Peter J Goadsby,et al. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT1B/1D) receptors. Br J Pharmacol. 1997 Nov; 122(5): 918–922. doi: 10.1038/sj.bjp.0701456.
分子式 C17H26ClN3O2S |
分子量 371.93 |
CAS号 143388-64-1 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 60 mg/mL |
Water 15 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT00487578 | Post Traumatic Headache | Drug: naratriptan HCl | Cady, Roger, M.D.|GlaxoSmithKline|Clinvest | Phase 4 | 2006-10-01 | 2013-02-04 |
NCT01726920 | Migraine|Headache | Drug: naratriptan + naproxen|Drug: naratriptan|Drug: naproxen | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | 2014-07-01 | 2016-03-15 |
NCT01376193 | Migraine Disorders | Drug: Naratriptan | GlaxoSmithKline | 2009-04-01 | 2013-05-16 | |
NCT01390324 | Migraine|Headache | Drug: Fixed-dose combination of naratriptan+naproxen|Drug: Naratriptan|Drug: Naproxen | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | 2011-12-01 | 2016-10-18 |
NCT01161654 | Migraine | Drug: naratriptan hydrochoride | Roxane Laboratories | 2007-08-01 | 2010-07-12 | |
NCT01161667 | Migraine | Drug: naratriptan hydrochloride | Roxane Laboratories | 2007-09-01 | 2010-07-12 | |
NCT01059604 | Migraine Disorders | Drug: Sumatriptan|Drug: Naratriptan|Drug: Sumatriptan-naproxen combination | GlaxoSmithKline | 2001-12-01 | 2014-10-30 | |
NCT01332383 | Migraine Disorders | Drug: Naratriptan | GlaxoSmithKline | 2009-05-01 | 2015-08-10 | |
NCT00282165 | Psychotic Disorders|Antisocial Personality Disorder|Impulse Regulation Disorder|Intermittent Explosive Disorder | Drug: naratriptan|Drug: placebo | UMC Utrecht|FPC De Kijvelanden, Poortugaal | Phase 4 | 2006-11-01 | 2015-01-23 |
NCT03066544 | Migraine | Drug: Bupivacaine|Drug: Naratriptan Pill|Drug: Dexamethasone|Drug: Ketorolac | Hartford HealthCare | 2016-11-30 | 2017-02-27 | |
NCT01435941 | Migraine Disorders | Drug: Non-steroidal anti-inflammatory drug (NSAID)|Drug: Triptan | GlaxoSmithKline | 2009-09-01 | 2011-09-21 | |
NCT01381497 | Migraine Disorders | Drug: Combination therapy of sumatriptan and naproxen sodium (SumaRT/Nap)|Drug: Triptan monotherapy | GlaxoSmithKline | 2010-03-01 | 2012-08-23 | |
NCT01381523 | Migraine Disorders | Drug: Combination therapy with sumatriptan and naproxen sodium (SumaRT/Nap)|Drug: Single-entity oral triptans | GlaxoSmithKline | 2010-11-01 | 2013-02-21 | |
NCT01086358 | Workplace Migraine Treatment | Drug: Usual prescribed triptan|Drug: Treximet for migraine treatment | The Cleveland Clinic|Pernix Theraputics LLC | Phase 4 | 2009-09-01 | 2016-08-10 |
NCT01332500 | Migraine Disorders | Drug: Sumatriptan/Naproxen combination|Drug: other oral triptans | GlaxoSmithKline | 2009-07-01 | 2011-04-19 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们